Kjell Mortier (Pharm., PhD) is fund manager for Novalis Biotech Incubation.
Prior to working for Novalis, Kjell acquired approximately 20-years experience in the biotech industry working in various scientific roles. At Ablynx, now part of Sanofi, he was responsible for the bioanalytical and immunogenicity part of dedicated clinical programs. At Eurofins, a leading CRO in the pharma, food and environmental industry, he supported the CMC-analytical part for various customers in the pharma industry.
Kjell also obtained certification for financial analysis at EHSAL Management school.
Kjell on linkedin